Failing to manage your Hashimoto’s hypothyroidism condition could lead to future autoimmune diseases. A recent study revealed that roughly one in six patients with Hashimoto’s has another autoimmune disease, most commonly:
atrophic gastritis, a condition in which the lining of the stomach is constantly inflamed
antiphospholipids syndrome, which may cause blood clots, miscarriages, or stillbirths, and
Hashimoto’s is an autoimmune disease that attacks and damages the thyroid gland, causing symptoms of hypothyroidism that include weight gain, cold hands and feet, depression, fatigue, and hair loss. In the United States, about 90 percent of hypothyroidism cases are due to Hashimoto’s.
Of the more than 1,500 patients with autoimmune thyroiditis (Hashimoto’s) who were included in the study, 16 percent were found to have an additional autoimmune disease. These patients also exhibited poor absorption of T4, chronic unexplained anemia, and recurring pregnancy losses. Thyroid hormone medication, which is the conventional treatment, may compensate for a damaged thyroid, but it does not address the underlying autoimmune condition. Continue reading →
Thanks to exciting new research, we can more effectively manage autoimmune diseases and chronic inflammatory disorders that plague so many people today. This new approach involves the use of two natural compounds, resveratrol and curcumin, which have been found to work better when taken together than separately.
Synergy between resveratrol and curcumin
Resveratrol is a compound derived from Japanese knotweed, and curcumin is derived from the popular curry spice turmeric. Both are well known for their antioxidant qualities.
However, newer research shows that taking them together creates a synergistic effect, making them potent tools for quenching the inflammation and damage associated with autoimmune flare-ups and chronic inflammation.
Successful for many autoimmune, inflammatory disorders
Examples of these disorders include autoimmune hypothyroidism (Hashimoto’s), Continue reading →
A new study shows hypothyroidism during pregnancy may be more common that previously thought, thanks to new clinical guidelines for evaluating thyroid stimulating hormone (TSH). The study revealed hypothyroidism in one in six pregnant women, a 10 percent increase after using a narrower TSH range.
The new guideline for normal TSH is now 0.3 to 3.0, narrower than the former guideline of 0.5 to 5.0. In functional medicine we use a range of 1.8 to 3.0.
Gestational hypothyroidism poses a number of risks, including miscarriage, hypertension, gestational diabetes, low-birth weight, and risk for lower IQ in the baby.
Hashimoto’s hypothyroidism screening important during pregnancy
Natural immune shifts during pregnancy, together with a genetic tendency and other predisposing factors, can trigger hypothyroidism in some women.
Hypothyroidism is an immune disease for most
For 90 percent of Americans, hypothyroidism is caused by Hashimoto’s, an autoimmune disease in which the immune system attacks and destroys the thyroid gland.
The immune system has two major arms of function, one that reacts immediately to an invader, and one that reacts later to produce antibodies. When one of these arms of becomes overly dominant it can trigger an autoimmune disease.
Going into pregnancy predisposed
Pregnancy and the postpartum periods naturally polarize the immune system. In the third trimester the delayed immune response is dominant. Postpartum the immediate immune reaction is stronger.
DISCLAIMER: Please be advised that any information or nutritional program mentioned on this website is not intended to diagnose, treat, cure, or prevent any disease or condition. This information is not intended to be a substitute for conventional medical service or advice from a licensed medical practitioner. Always consult with a qualified medical professional before making changes to your diet, medication, lifestyle, or exercise activities.